Vascular integrity is disturbed in shock contributing to clinical appearance and serious outcomes. While angiopoietin (Ang)-1 protects from vascular inflammation and leakage, Ang-2 disrupts endothelial barrier function. The imbalance of Ang-1 and Ang-2, their association to haemodynamic deterioration, and their prognostic relevance are not known and, thus, were prospectively evaluated in patients with cardiogenic shock (CS) in this study.
Introduction
Cardiogenic shock (CS) is the leading cause of in-hospital death in patients with acute myocardial infarction (AMI), and its lethality remained constantly high at 50 -70% for the last three decades. 1, 2 Cardiogenic shock caused after AMI has been viewed as simply a haemodynamic problem with severe myocardial ischaemia or infarction leading to impaired left ventricular contractility and decreased cardiac output. The compensatory neurohormonal response resulting in systemic vasoconstriction, tachycardia and fluid retention, and worsening myocardial ischaemia, extremity and vital organ perfusion, 3, 4 representing maladaptive mechanisms, initiating a downward spiral resulting in shock with tissue hypoperfusion, hypoxaemia, enhanced proinflammatory cytokine and nitric oxide synthase expression, and consecutively to a paradoxical reduced systemic vascular resistance (SVR), promoting a systemic inflammatory response syndrome (SIRS). 5 In the SHOCK trial about one-fifth of patients with CS complicating myocardial infarction showed clinical signs of SIRS. 6 The observation of SIRS at the onset of CS suggests that inappropriate vasodilatation, impaired vascular barrier function, and capillary leakage may play important roles in persistence of shock and in risk of death. 6 Attempts to inhibit inflammatory responses did not show benefit. 7 Recently, it was reported that endothelial barrier function is controlled by the endothelial-specific angiopoietin-(Ang)-Tie-2 ligand-receptor system. 8 -10 Binding of the agonist Ang-1 to the Tie-2 receptor promotes vessel integrity, inhibits vascular leakage, and suppresses inflammatory gene expression. 11, 12 In contrast, Ang-2 inhibits binding of Ang-1 to Tie-2, disrupting the Tie-2 signalling resulting in impaired endothelial integrity. 11, 13, 14 The Ang -Tie-signalling system plays a crucial role in several critical illness states. 15 In patients with sepsis and septic shock, Ang-2 levels in plasma were increased and correlated with disease severity, whereas Ang-1 levels were decreased. 16 The same Ang-1/ Ang-2 pattern was seen in patients with acute lung injury 17 -19 and early after trauma. 20 Elevated Ang-2 concentrations correlated with the severity of illness and outcome as assessed by critical illness scores. 17, 18, 21 Patients with cardiovascular disorders also exhibit changes in the Ang-Tie system. Angiopoietin-2 concentrations are increased in acute coronary syndromes 22 and congestive heart failure. 23 Despite the growing body of evidence in critically illness, the role of Ang-1 and Ang-2 in the setting of CS has not been studied. We prospectively evaluated the incidence and prognostic relevance of circulating Angs by the 28-day mortality and the survival time (follow-up time 1 year) and their association to haemodynamic disorders in patients with CS on a medical intensive care unit (ICU).
Methods

Patients and study design
With approval of the institutional review board and according to the WHO guidelines for good clinical practice 24 we evaluated all critically ill patients with CS on the medical ICU of the University Hospital of the Saarland from September 2008 to October 2010. Informed written consent was obtained from enrolled patients or substitute decision-makers. Cardiogenic shock was defined as clinical signs of hypoperfusion cool extremities owing to centralization, decreased urine output, or alteration in the mental status. Clinical diagnosis was confirmed by haemodynamic parameters such as a systolic blood pressure ,90 mmHg in the absence of hypovolaemia or vasopressors, a reduction in cardiac index (CI) (,1.8 L/min/m 2 ) and/ or an elevation pulmonary capillary wedge pressure (PCWP) .18 mmHg. 25 Critical illness was defined by a commonly used score in intensive care medicine [Simplified Acute Physiology Score II (SAPS-II)]. 26 Herein, critical illness and multiple organ dysfunction syndromes (MODS) were defined as a minimum SAPS-II score of 30 points. As shown in Figure 1 , all patients with clinical signs of CS as described above were assigned to haemodynamic monitoring and were evaluated for the study. Patients resuscitated before admission to the ICU were excluded. All participants were followed from the baseline examination until Day 28 by vital status registry and clinical examination and after 1 year by phone call. Consecutively, 96 patients were analysed for 28-day mortality, prognostic biomarkers of CS, and changes in circulating Angs. In cases when CS was secondary to myocardial infarction a percutaneous coronary intervention (PCI) was done if necessary. The decision to intra-aortic balloon pump (IABP) was made by the physician in charge according to clinical needs. The use of inotropes, vasopressors, and further concomitant treatments was decided according to the judgement of the treating physician. All assays and haemodynamic measurements were performed in duplicate by investigators blinded to patients' characteristics and outcome.
Controls
Two control groups were accomplished. The first one consisted of 20 age-matched patients with uncomplicated AMI. The second control group composed of 20 age-matched healthy volunteers without a history of any disease [referred to as healthy controls (HCs)].
Blood sampling and laboratory analysis
Blood samples were collected immediately after admission to the ICU and at Day 3. All samples were collected in ethylenediaminetetraacetic acid tubes and were immediately placed on ice. Within 30 min of collection, samples were centrifuged at 3000 g for 10 min, divided into aliquots and stored at 2708C until analysis. Plasma Ang-1, Ang-2, and N-terminal fragment of the B-type natriuretic peptide (NT-pro-BNP) were measured by commercially available enzyme-linked immunosorbent assays (ELISA) (Ang-1/-2: R&D Systems, Minneapolis, MN, USA; NT-pro-BNP: Roche Diagnostics, Mannheim, Germany). The expression of the receptor for advanced glycation end products (RAGE) and toll-like receptor 2 (TLR2) on monocytes was measured by flow cytometry as described previously. 27, 28 The following laboratory tests were measured in clinical routine: arterial blood gases were analysed every 4 h; haemoglobin, haematocrit, red and white blood cells, platelets, creatinine, urea, troponin T, creatine kinase, and C-reactive protein were measured daily.
Haemodynamic measurements
According to the recommendations and guidelines 29 in patients with CS haemodymanic measurements were done by pulmonary catheters or by the pulse contour cardiac output (PiCCO) system. All these techniques represent routine clinical practice in this institution. The following haemodynamic parameters were collected: heart rate (HR), mean arterial blood pressure (MAP), mean PCWP, mean pulmonary artery pressure (PAP), CI, mixed venous oxygen saturation (SvO 2 ), cardiac power index (CPI), SVR. In only one case of a pregnant woman, the PiCCO system was used and central venous oxygen saturation (ScvO 2 ) was measured. For analysis ScvO 2 was adjusted to SvO 2 . To evaluate the prognostic value of biomarkers, a receiver operating characteristic (ROC) analysis was performed. The cut-off points were determined with a specificity of 80%. To compare the survival in several groups, Kaplan -Meier survival curves were calculated and tested by the log-rank test. The adjustment of the different predictor variables was performed using Cox regression.
Statistical analysis
The results were considered statistically significant with a P-value ,0.05. All tests were used two-sided. All statistical analyses were performed with StatView (SAS Institute, Inc., Cary, NC, USA).
Results
Baseline characteristics
This prospective monocentric clinical study was performed at an interdisciplinary medical ICU. During a study period of 2 years in 96 of 1594 critically ill patients CS was diagnosed (6%). Consecutively, 96 patients with CS were analysed ( Figure 1 ) and distributed into two groups according the 28-day mortality in survivors and non-survivors. The 28-day-mortality rate was 37.5%; the 1-year-mortality rate 61.5%. The main demographic data are depicted in Table 1 . Between survivors and non-survivors there were no differences in age, gender, cardiovascular risk factors (except the use of tobacco), and reasons for CS.
Critical illness
Patients with CS were monitored at baseline and daily thereafter. Already at admission the severity of critical illness, measured by the SAPS-II score, differed significantly (P , 0.001, Table 1 ). Whereas the SAPS-II score decreased in survivors, we observed a timedependent significant increase of the SAPS-II score in nonsurvivors (P , 0.001, Table 2 ).
Haemodynamics and cardiac function
There were no significant differences with regard to the left ventricular ejection fraction (EF) between survivors and non-survivors of CS. But non-survivors had significant larger infarction sizes as measured by troponin T (P ¼ 0.019) and creatine kinase releases (P ¼ 0.013, Table 2 ). On admission, HRs were similar in both groups (P ¼ 0.056) and decreased significantly in survivors (P , 0.001). In contrast, HRs increased in non-survivors and were significantly different between both groups within the following 3 days (P , 0.001). In non-survivors MAP, CI, and CPI were already significantly decreased at baseline and further declined (P , 0.001, Table 2 ). But in survivors MAP, CI, CPI increased significantly under therapy (P , 0.001, Table 2 ). The mixed SvO 2 measured initially at admission was comparable in all patients with CS (P ¼ 0.061, Table 2 ). According to the changes of CI in non-survivors SvO 2 further decreased, whereas it significantly increased in survivors (P , 0.001, Table 2 ).
Plasma levels of angiopoietins
Baseline mean Ang-2 levels were 1.5 -2.5-fold higher in patients with AMI or CS compared with HCs (P , 0.001, Table 1 ). These Ang-2 levels in patients with CS were widely distributed at admission. They ranged from 370 to 3874 pg/mL in survivors and from 487 to 3976 pg/mL in non-survivors; their mean values (1668 + 954 vs. 2502 + 1171 pg/mL) were significantly elevated in the group of non-survivors (P ¼ 0.001, Figure 2 and Table 2 ). Of note, as shown in Figure 2 , during the follow-up of 3 days highly elevated Ang-2 levels decreased significantly in patients with CS who survived (P , 0.001), whereas in non-survivors normal-or moderate-elevated Ang-2 levels increased rapidly and highelevated levels remained markedly elevated (P , 0.001, Figure 2 and Table 2 ). For Ang-1 levels no differences were detected between HCs and AMI controls at baseline (P ¼ 0.093, Figure 3) , whereas in all patients with CS Ang-1 levels were significantly decreased (P , 0.001, Figure 3 and Table 1 ). The mean Ang-1 levels in survivors increased significantly within 3 days (P , 0.001), Circulating angiopoietins and cardiovascular mortality but did not reach the values of HCs. In contrast, there was a further decrease in Ang-1 levels in patients with CS who died (P , 0.001). In these patients the lowest Ang-1 levels were measured ( Figure 3 and Table 2 ). Strikingly, Ang-1 levels showed an inverse correlation with Ang-2 levels on admission (r ¼ 20.720, r 2 ¼ 0.513, n ¼ 96, P , 0.001) and on Day 3 (r ¼ 20.848, r 2 ¼ 0.719, n ¼ 93, P , 0.001).
Receiver operation characteristics for 28-day mortality in cardiogenic shock
Using ROC curve analysis continuous biomarkers were investigated for their accuracy predicting 28-day mortality in CS. Table 3 shows for all of these variables area under the curve (AUC), P-values, and 'cut-off' points for an 80% specificity to determine 28-day mortality in patients with CS. Of these variables, monocytic RAGE expression and CPI showed highest AUC values, reflecting a strong prognostic significance in predicting mortality in CS. Similarly, SAPS-II and Ang-2 showed high AUC values on a high level of significance. Thus, Ang-2 levels are also of prognostic relevance. An Ang-2 value .2500 pg/mL at admission on ICU predicts 28-day mortality with an 80% specificity ( Table 3) .
Predictors for mortality in cardiogenic shock
In CS, CPI is a strong predictor of adverse outcomes, followed by clinical prognosis scores (e.g. SAPS-II biomarker in CS. In the present study, SAPS-II, CPI, RAGE expression on monocytes, and ANG-2 were identified as prognostic relevant variables by ROC analysis ( Table 3) . These continuous variables were completed by the following categorical variables-the underlying causes of CS (ischaemic vs. non-ischaemic), the use of vasopressors, the use of PCI, and IABP, the use of mechanical ventilation. Continuous and categorical variables were dichotomized and analysed by the Cox proportional hazard model ( Table 4) . Survival analysis was performed by using the Cox proportional hazard model. Cardiac power index, monocytic RAGE expression, Ang-2, and ischaemic reasons for CS were significantly predictive for 1-year mortality in CS. Compared with the well-established CPI [hazard ratio (HR) 1.53; 95% CI: 0.95 -2.48; P , 0.031], monocytic RAGE expression (HR: 2.44; 95% CI: 1.47-4.03; P , 0.001), and Ang-2 (HR: 2.11; 95% CI: 1.03-4.36; P , 0.001) were significantly predictive for the clinical outcome ( Table 4) .
Angiopoietin-2 levels .2500 pg/mL at admission had a sensitivity of 61% and a specificity of 80% to determine 28-day mortality in CS. In the Kaplan-Meier survival analysis patients with CS and an Ang-2 level .2500 pg/mL at admission had a higher mortality rate (log-rank P , 0.001) (Figure 4 ).
Angiopoietins are closely related to the course of cardiogenic shock
The cardiac power index and mixed SvO 2 are closely related to the clinical course of CS. Plasma Ang-2 levels were inversely correlated to both CPI and SvO 2 ( Figure 5) . On admission, a statistically significant but very weak correlation of Ang-2 to CPI (r 2 ¼ 0.183; P , 0.001; Figure 5A ) was detected. During a followup of 3 days a deterioration in CPI was accompanied by a significant and strongly correlated decrease in angiopoetin-2 (r 2 ¼ 0.785, P , 0.001; Figure 5B ). For SvO 2 an even stronger correlation was found at Day 3 (admission: r 2 ¼ 0.506, P , 0.001; Day 3: r 2 ¼ 0.915, P , 0.001; Figure 5C and D). Similar correlations were found for angiopoetin-1 and both CPI and SvO 2 ( Figure 6 ). In contrast to Ang-2 with its inverse correlations for Ang-1-positive correlations were noticed. It could be assumed that increasing Ang-2 levels are associated with a capillary leakage and consecutively with a reduced SVR. We found no significant correlation between Ang-2 and SVR (admission: r 2 ¼ 0.003, P ¼ 0.536; day 3:
Increasing Ang-2 levels were also associated with an ongoing CS and the necessity of increased doses of vasopressors. This could be one reason for the lack of correlation between Ang-2 and SVR.
Discussion
The loss of vascular integrity and MODS is final common pathways in all cases of ongoing shock including CS associated with deleterious outcomes. 
10 (17) 18 (30) 12 (33) 27 ( . Continuous data are expressed as mean with SD (minimum; maximum) and compared by the Mann -Whitney test, paired t-test, or one-way ANOVA. SAPS-II, Simplified Acute Physiology Score; MAP, mean arterial pressure; PCWP, mean pulmonary capillary wedge pressure; PAP, mean pulmonary artery pressure; CI, cardiac index; CPI, cardiac power index; SVR, systemic vascular resistance mean; SvO 2 , mixed venous oxygen saturation; EF, ejection fraction; CRP, C-reactive protein; NT-pro-BNP, brain natriuretic peptide, RAGE, receptor for advanced glycation end products; TLR2, Toll-like receptor-2; PCI, percutaneous coronary intervention; IABP, intra-aortic balloon pump.
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course and severity of CS. (iii) Furthermore, time-dependent increase in Ang-2 and a decrease in Ang-1 were associated with an adverse outcome and (iv) Ang-2 levels .2500 pg/mL at admission emerged as an independent predictor of 28-day and 1-year mortality in CS.
The Ang-Tie receptor-ligand system has been identified as a critical regulator of vascular function 8, 9, 13, 14, 30, 31 and circulating levels of Ang-1 and Ang-2 may provide valuable information regarding the status of endothelial dysfunction and organ injury in sepsis, 21 ,30,32 acute lung injury, 19, 33 and, as these data show, Continuous variables were dichotomized according to their 'cut-off' points (see Table 3 ). Categorical variables were also dichotomized. SAPS-II, Simplified Acute Physiology Score; NT-pro-BNP, brain natriuretic peptide; RAGE, receptor for advanced glycation end products; PCI, percutaneous coronary intervention; IABP, intra-aortic balloon pump. Figure 4 Kaplan -Meier survival curves of cardiogenic shock using angiopoietin-2 levels on admission. Cut-off values based on receiver operating characteristic analysis. Log-rank test (P-value).
also in CS. Compared with age-matched HCs Ang-2 levels were elevated up to 1.5-fold in patients with AMI and three-fold in patients with CS. In contrast, Ang-1 remained nearly unchanged in AMI and fell down to 35-fold in CS. Our results of Angs in AMI were in accordance with data from others in uncomplicated acute coronary syndromes; 23 but up to now no data were available for CS. Looking for patients with septic shock a 30-fold increase for Ang-2 and a 60-fold decrease for Ang-1 were found, compared with a non-age-matched HC group. 21 In all the patients with CS examined in our study, high plasma Ang-2 levels correlated strongly with morbidity, as measured by the SAPS-II score, and 28-day mortality. Angiopoietin-2 levels on admission were relatively widespread and lacked discriminative utility, but were associated with mortality in longitudinal analysis because of pronounced decreases in survivors and increases in non-survivors over time. The cardiac power index is a valuable tool for sensitive and specific assessment of cardiac function, shown to correlate with outcomes and represents a strong independent predictor of in-hospital mortality in patients with CS. 34 -37 Recently, we found the role of the monocytic expression of the RAGE as an independent predictor of mortality in patients with CS. 28 In the present study, we were able to confirm these results once more: CPI ,0.2 L/min/m 2 , monocytic RAGE expression .104 MFI, Ang-2-levels .2500 pg/mL, and the use of vasopressors emerged as independent predictors of mortality in patients with CS. The HR of 1-year mortality in patients with CS and an Ang-2-level .2500 pg/mL was 2.11-fold higher than in patients with an Ang-2 level ,2500 pg/mL. In the Kaplan-Meier survival analysis, patients Circulating angiopoietins and cardiovascular mortality with an Ang-2-level .2500 pg/mL had the highest mortality rates. Larger studies may be required to define the cut-off point with the greatest diagnostic accuracy more precisely.
Prior studies have observed an association between admission levels of Ang-2 and mortality rates in sepsis. 21, 30, 32, 33, 38, 39 Consistent with our study, their investigations have also shown a significant association between mortality and Ang-2 levels measured in the course of time. 30, 39 Ang-2 has proinflammatory effects, mediates vascular leakage, 8 and is rapidly induced and released upon various stimuli including inflammatory cytokines, 8 activated platelets and leucocytes, 9 changes in blood flow, and oxygenation. 40, 41 In our study, elevated Ang-2 levels were closely associated with decreased CPI and SvO 2 . In the longitudinal analysis, over time these inverse correlations became even stronger. The pathophysiological mechanisms are likely to be involved in the outcome of shock patients. The important role of the interplay of Ang-1 and Ang-2 in these mechanisms led us to suggest that Angs are also potential treatment targets to improve the outcomes of these deleterious conditions. In patients with CS, the haemodynamic parameters represent hypoperfusion and consecutively organ and tissue hypoxia. Our findings of the association between Ang-2 and SvO 2 were in agreement with results of patients with pulmonary arterial hypertension. 40 In vitro studies have shown that the exposure of endothelial cells to hypoxia-induced Ang-2 expression. 41 It was conceivable that Ang-2 expression might be regulated by hypoxia-inducible factor-1, but cyclooxygenase-2-dependent prostanoids were shown to play an important role in the regulation of hypoxia-induced Ang-2 expression. 41 Therefore, it is likely that hypoperfusion and hypoxia induce an increases in Ang-2 thereby initiating a vicious cycle leading to deterioration of endothelial dysintegrity and further to the downhill spiral resulting in death. Several in vitro and in vivo animal studies have shown that Ang-1 stabilizes the endothelium and protects against the deleterious effects of sepsis on organ function. 11, 31, 42, 43 The relevance of Ang-1 levels as a predictor for mortality remained unclear. In our study, we observed low admission plasma levels of Ang-1 in patients with CS and a further decrease in patients who died within 28 days. But multivariate analysis and ROC analysis were not so powerful that the prediction of mortality could be clearly estimated. Also, previously conducted observational studies of sepsis have not consistently shown a correlation between Ang-1 levels and disease severity, although low levels of circulating Ang-1 in septic patients compared with normal controls have been documented. 17, 18, 30, 33 It is currently accepted that not only impaired macrocirulation measured by CPI, but also impaired microcirculation predicts poor outcome in CS. 44, 45 Microcirculation can be measured bedside using two-dimensional video images of sublingual perfused capillary density. 44, 45 Sublingual perfused capillary density is a surrogate marker for organ hypoperfusion in CS. 44 The mechanisms involved in the pathogenesis of microcirculatory disturbances and consecutively MODS in CS remain largely unknown. Angiopoietins play a crucial role in endothelial function, vessel integrity, and vascular leakage. It could by hypothesized that changes of the AngTie-signalling system might modulate microcirculation in CS which could either be directly visualized at bedside by measuring sublingual perfused capillary density. Our study is limited by its single-centre design and failing measurements of tissue oxygenation and microcirulatory perfusion. Therefore, in clinical settings and especially in CS an interaction between Angs and tissue oxygenation could only be assumed but is not proved yet. Strength is given to our study by the high number of consecutively recruited patients with CS, the longitudinal data collection and analysis, and the reference to age-matched healthy persons and AMI controls. This provides important insights into the patterns of angiopoetins in patients with CS. Furthermore, additional evidence for the potential pathophysiological role of Angs in CS is given, supporting further investigations of the Ang-Tie pathway as a therapeutic target in CS.
Conclusion
This study provides evidence for the important role of circulating Angs as a biomarker for the loss of vascular integrity, tissue hypoperfusion and hypoxaemia, and ongoing CS. Circulating Angs are closely related to the course and severity of CS. Angiopoietin-2 levels .2500 pg/mL at admission emerged as an independent predictor of 28-day and 1-year mortality in CS.
